转化生物医学

  • 国际标准期刊号: 2172-0479
  • 期刊 h 指数: 16
  • 期刊引用分数: 5.91
  • 期刊影响因子: 3.66
索引于
  • 打开 J 门
  • Genamics 期刊搜索
  • 期刊目录
  • 研究圣经
  • 全球影响因子 (GIF)
  • 中国知网(CNKI)
  • 引用因子
  • 西马戈
  • 电子期刊图书馆
  • 研究期刊索引目录 (DRJI)
  • OCLC-WorldCat
  • 普罗奎斯特传票
  • 普布隆斯
  • 米亚尔
  • 大学教育资助委员会
  • 日内瓦医学教育与研究基金会
  • 谷歌学术
  • 夏尔巴罗密欧
  • 秘密搜索引擎实验室
  • 研究之门
分享此页面

抽象的

Precision Medicine and Translation of Human-Induced Pluripotent Stem Cells: Review

Kenza Tani

The future of biomedical research has undergone a significant change as a result of the possibility of altering the flexibility of terminally differentiated cells toward pluripotency. Human-induced pluripotent stem cells (iPSCs) offer a fresh source of therapeutic cells free of the moral quandaries or immunological restrictions associated with human embryonic stem cells. iPSCs also provide significant benefits over traditional approaches of studying human diseases. Three key uses of iPSC technology have emerged since its inception: disease modelling, regenerative medicine, and drug development. Here, we thoroughly cover the most recent developments in iPSC technology in connection to fundamental, clinical, and public health.

Keywords

Pluripotent; Stem Cells; Translation

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证